Matti A Hiob1,2, Andy E Trane3,4, Steven G Wise1,5,6, Pascal N Bernatchez3,4, Anthony S Weiss1,2,7. 1. School of Life & Environmental Biosciences, University of Sydney, Sydney, NSW 2006, Australia. 2. Charles Perkins Centre, University of Sydney, Sydney, NSW 2006, Australia. 3. Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, V6Z1Y6, Canada. 4. Department of Anesthesiology, Pharmacology & Therapeutics, University of British Columbia, Vancouver, Canada. 5. Sydney Medical School, University of Sydney, NSW 2006, Australia. 6. The Heart Research Institute, Sydney, NSW, 2042, Australia. 7. Bosch Institute, University of Sydney, Sydney, NSW 2006, Australia.
Abstract
AIMS: This study aimed to characterize the role of tropoelastin in eliciting a nitric oxide response in endothelial cells. MATERIALS AND METHODS: Nitric oxide production in cells was quantified following the addition of known nitric oxide synthase pathway inhibitors such as LNAME and 1400W. The effect of eNOS siRNA knockdowns was studied using western blotting and assessed in the presence of PI3K-inhibitor, wortmannin. RESULTS: Tropoelastin-induced nitric oxide production was LNAME and wortmannin sensitive, while being unaffected by treatment with 1400W. CONCLUSION: Tropoelastin acts through a PI3K-specific pathway that leads to the phosphorylation of eNOS to enhance nitric oxide production in endothelial cells. This result points to the benefit of the use of tropoelastin in vascular applications, where NO production is a characteristic marker of vascular health.
AIMS: This study aimed to characterize the role of tropoelastin in eliciting a nitric oxide response in endothelial cells. MATERIALS AND METHODS:Nitric oxide production in cells was quantified following the addition of known nitric oxide synthase pathway inhibitors such as LNAME and 1400W. The effect of eNOS siRNA knockdowns was studied using western blotting and assessed in the presence of PI3K-inhibitor, wortmannin. RESULTS:Tropoelastin-induced nitric oxide production was LNAME and wortmannin sensitive, while being unaffected by treatment with 1400W. CONCLUSION:Tropoelastin acts through a PI3K-specific pathway that leads to the phosphorylation of eNOS to enhance nitric oxide production in endothelial cells. This result points to the benefit of the use of tropoelastin in vascular applications, where NO production is a characteristic marker of vascular health.
Authors: Steven G Wise; Michael J Byrom; Anna Waterhouse; Paul G Bannon; Anthony S Weiss; Martin K C Ng Journal: Acta Biomater Date: 2010-07-23 Impact factor: 8.947
Authors: D Fulton; J P Gratton; T J McCabe; J Fontana; Y Fujio; K Walsh; T F Franke; A Papapetropoulos; W C Sessa Journal: Nature Date: 1999-06-10 Impact factor: 49.962
Authors: Jessica F Almine; Steven G Wise; Matti Hiob; Neeraj Kumar Singh; Krishna Kumar Tiwari; Shireen Vali; Taher Abbasi; Anthony S Weiss Journal: FASEB J Date: 2013-05-13 Impact factor: 5.191
Authors: Errol S Wijelath; Jacqueline Murray; Salman Rahman; Yatin Patel; Atsushi Ishida; Kurt Strand; Salim Aziz; Carlos Cardona; William P Hammond; Geoffrey F Savidge; Shahin Rafii; Michael Sobel Journal: Circ Res Date: 2002-07-12 Impact factor: 17.367
Authors: Aloke V Finn; Gaku Nakazawa; Michael Joner; Frank D Kolodgie; Erik K Mont; Herman K Gold; Renu Virmani Journal: Arterioscler Thromb Vasc Biol Date: 2007-05-17 Impact factor: 8.311
Authors: Steven G Wise; Giselle C Yeo; Matti A Hiob; Jelena Rnjak-Kovacina; David L Kaplan; Martin K C Ng; Anthony S Weiss Journal: Acta Biomater Date: 2013-08-11 Impact factor: 8.947
Authors: Andy E Trane; Dmitri Pavlov; Arpeeta Sharma; Uzma Saqib; Kelvin Lau; Filip van Petegem; Richard D Minshall; Linda J Roman; Pascal N Bernatchez Journal: J Biol Chem Date: 2014-03-19 Impact factor: 5.157